tyrosine has been researched along with tautomycetin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bothwell, A; Chae, WJ; Chang, EJ; Han, DJ; Han, JH; Lee, HK; Lee, SK; Morio, T; Shim, JH; Yang, JJ | 1 |
Chan, RJ; Gunawan, AM; Huang, SX; Liu, S; Luo, Y; Shen, B; Shen, W; Wang, L; Wu, L; Yang, Z; Yu, X; Yu, Z; Zhang, ZY | 1 |
2 other study(ies) available for tyrosine and tautomycetin
Article | Year |
---|---|
Immunosuppressive effects of tautomycetin in vivo and in vitro via T cell-specific apoptosis induction.
Topics: Animals; Antifungal Agents; Apoptosis; Caspase 3; Caspase 9; Caspases; Cell Division; Cyclosporine; Furans; Heart Transplantation; HeLa Cells; Humans; Immunosuppressive Agents; Jurkat Cells; Lipids; Lymphocyte Activation; Molecular Structure; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred Lew; Rats, Wistar; Receptor-CD3 Complex, Antigen, T-Cell; Signal Transduction; T-Lymphocytes; Tyrosine | 2002 |
SHP2 is a target of the immunosuppressant tautomycetin.
Topics: Amino Acid Sequence; Cell Differentiation; Cell Proliferation; Enzyme Activation; Enzyme Inhibitors; Furans; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Jurkat Cells; Lipids; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Molecular; Molecular Sequence Data; Monocytes; Phosphorylation; Protein Conformation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyrans; Signal Transduction; Spiro Compounds; Substrate Specificity; Tyrosine | 2011 |